Buruli ulcer
Peer reviewed by Dr Toni Hazell, FRCGPLast updated by Dr Colin Tidy, MRCGPLast updated 22 Sept 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Medical Professionals
Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find one of our health articles more useful.
Synonyms: Bairnsdale ulcer, Daintree ulcer, Mossman ulcer, Searl ulcer, Kakerifu ulcer, Toro ulcer
Background1
Buruli ulcer is a chronic debilitating disease that mainly affects the skin and sometimes bone. The name Buruli comes from an area of Uganda where many cases were reported in the 1960s.
Buruli ulcer is caused by Mycobacterium ulcerans and belongs to the family of bacteria that causes tuberculosis and leprosy. Although the causative organism of Buruli ulcer is an environmental bacterium, the mode of transmission to humans remains unknown. The organism produces a unique toxin – mycolactone – that causes the damage to the skin. Early diagnosis and treatment are crucial to minimising morbidity, costs and prevent long-term disability.
Epidemiology1
The largest number of endemic cases occurs in central and western Africa. Other affected areas include Australia, South-East Asia, and sporadic cases in Central America and South America.
The annual number of suspected Buruli ulcer cases reported globally was around 5000 cases up until 2010, when it started to decrease until 2016, reaching its minimum with 1961 cases reported. The number of cases then started to rise again every year, up to 2713 cases in 2018. Since then, the numbers of cases have been declining in 2019 (2271); 2020 (1458) and 2021 (1370). The reductions seen in 2020 and 2021 could be linked to the impact of COVID-19 on active detection activities.
In Africa, about half of the patients are children under 15 years. In Australia, the average age is around 60 years.
The exact mode of transmission of M. ulcerans is still unknown.
Risk factors
For many years the mode of transmission has been unknown, however use of polymerase chain reaction (PCR) has revealed that water bugs and small fish carry M. ulcerans in their salivary glands.2
Many victims are agricultural workers or children who live near slow-flowing or stagnant water.
Direct skin inoculation is believed to be the route of transmission by a bite.
Presentation1
The incubation period varies from 2 months to several years. The initial injury often goes unnoticed.
Buruli ulcer often starts as a painless swelling (nodule), a large painless area of induration (plaque) or a diffuse painless swelling of the legs, arms or face (oedema). The disease may progress with no pain and fever.
Without treatment or sometimes during antibiotics treatment, the nodule, plaque or oedema will ulcerate within 4 weeks. Bone is occasionally affected, causing deformities.
The disease has been classified into three categories of severity:
Category I, single small lesion (32%) less than 5 cm on diameter.
Category II, non-ulcerative and ulcerative plaque and oedematous forms between 5-15 cm (35%).
Category III lesions more than 15 cm in diameter including, disseminated and mixed forms such as, osteomyelitis and joint involvement (33%).
Lesions frequently occur in the limbs: 35% on the upper limbs, 55% on the lower limbs, and 10% on the other parts of the body.
Differential diagnosis1
These include:
Leprosy
Yaws
Deep fungal infection such as blastomycosis or coccidioidomycosis
Mycetoma.
Ulcerative squamous cell carcinoma
Other causes of ulceration such as diabetes, arterial and venous insufficiency lesion.
Investigations1 3
In most cases, experienced health professionals in endemic areas can make a reliable clinical diagnosis.
Four standard laboratory methods can be used to confirm Buruli ulcer:
Polymerase chain reaction (PCR).
Direct microscopy.
Histopathology.
Culture: the bacterium grows best at temperatures between 29–33 °C and needs a low (2.5%) oxygen concentration.
X-rays and ultrasound may be required for deep lesions.
Management1
Treatment consists of a combination of antibiotics and interventions such as wound and lymphoedema management and surgery.
Daily oral rifampin and intramuscular streptomycin for 8 weeks was introduced in the early 2000s and is recommended by the WHO:4
A review of treatment studies performed in 8 African countries and one in Australia showed that this regimen achieved on average a 50% cure rate.
This antibiotic regimen is very effective for lesions that are less than 10 cm in diameter, as these patients may not require surgery.
A recent study suggests the combination of rifampicin (10 mg/kg once daily) and clarithromycin (7.5 mg/kg twice daily) is now the recommended treatment.
In Australia, a combination of rifampicin (10 mg/kg once daily) and moxifloxacin (400 mg once daily) is routinely used with good results, but its effectiveness has not been proven in a randomised trial.
Priority research for treatment is to shorten the duration of treatment from 8 weeks.
Interventions such as wound and lymphoedema management and surgery (mainly debridement and skin grafting) are used to speed up healing, thereby shortening the duration of hospitalisation.
Physiotherapy is needed in severe cases to prevent disability. Those left with disability require long-term rehabilitation.
Complications
Buruli ulcer has been associated with osteomyelitis during the ulcerative stage.
Scarring, contractures, and lymphoedema may cause severe deformity and psychosocial difficulties.
Untreated advanced disease can cause death by sepsis.
Prognosis3
Early case detection and rapid initiation of treatment are key elements to prevent the development of large, disfiguring ulcers often associated with permanent physical disability and stigma.
Early aggressive surgical treatment appears to provide the best chance of cure.
Ulcers have been reported to heal spontaneously, but can result in a depressed scar with contractures and consequent severe deformities.
Circumferential involvement of extremities can require amputation.
Prevention1
There are currently no primary preventive measures for Buruli ulcer. The mode of transmission is not known.
Bacillus Calmette–Guérin (BCG) vaccination appears to provide limited protection.
The objective of Buruli ulcer control is to minimise the suffering, disabilities and socioeconomic burden. Early detection and antibiotic treatment are the cornerstones of the control strategy.
Patient picks for Dermatology

Professional
Leg ulcers
See also the separate Venous Leg Ulcers Venous leg ulcers article. What is a leg ulcer. A leg ulcer is defined as the loss of skin below the knee on the leg or foot, which takes more than two weeks to heal. Leg ulcer - venous; NICE CKS, August 2021 (UK access only) 66099 : CKS Leg ulcer - venous What causes leg ulcers. (Aetiology) The aetiology of.
by Dr Colin Tidy, MRCGP

Professional
Oral ulceration
What are oral ulcers. Oral ulcers are characterised by a loss of the mucosal layer within the mouth. (Epidemiology) Aphthous ulcer; NICE CKS, March 2024 (UK access only) 63387 : CKS Aphthous ulcer Oral ulceration is a common condition. 25% of the global population are thought to be affected by recurrent aphthous ulcers, one of the most common.
by Dr Toni Hazell, FRCGP

Professional
Venous leg ulcers
Appearance of venous leg ulcers Venous ulcers are usually large, shallow, painless and situated around the medial or lateral malleoli. Norman G, Westby MJ, Rithalia AD, et al; Dressings and topical agents for treating venous leg ulcers. Cochrane Database Syst Rev. 2018 Jun 15;6(6):CD012583. doi: 10.1002/14651858.CD012583.pub2. 66199 : Dressings.
by Dr Colin Tidy, MRCGP

Professional
Peptic ulcer disease
A gastric or duodenal ulcer is a breach in the epithelium of the gastric or duodenal mucosa that penetrates the muscularis mucosae, which is confirmed on endoscopy. Gastric and duodenal ulceration is collectively known as peptic ulcer disease. Dyspepsia - proven peptic ulcer; NICE CKS, May 2024 (UK access only) 67896 : CKS Dyspepsia - proven.
by Dr Colin Tidy, MRCGP

Professional
Pressure ulcers
Synonyms: pressure sores, bed sores, decubitus ulcers What are pressure ulcers. Pressure ulcers occur when skin and underlying tissues are placed under pressure that impairs blood supply, leading to tissue damage. Pressure ulcers may present as persistently red, blistered, broken or necrotic skin and may extend to underlying structures ....
by Dr Doug McKechnie, MRCGP

Professional
Ulcerative colitis
What is ulcerative colitis. Ulcerative colitis is an idiopathic chronic inflammatory disease of the colon that follows a course of relapse and remission. In a small number of cases, ulcerative colitis is associated with extra-intestinal features. (Epidemiology) Ulcerative colitis; NICE CKS, March 2024 (UK access only) 64860 : CKS Ulcerative.
by Dr Colin Tidy, MRCGP
Exclusive updates for healthcare professionals
Stay informed with the latest clinical updates, professional insights, and evidence-based guidance. The Patient Pro newsletter curates essential content for healthcare professionals—delivered straight to your inbox.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.
Further reading and references
- Buruli ulcer; DermNet.
- Buruli ulcer (Mycobacterium ulcerans infection); World Health Organization (WHO).
- Wansbrough-Jones M, Phillips R; Buruli ulcer: emerging from obscurity. Lancet. 2006 Jun 3;367(9525):1849-58.
- Roltgen K, Cruz I, Ndung'u JM, et al; Laboratory Diagnosis of Buruli Ulcer: Challenges and Future Perspectives. April 2019.
- Guarner J; Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease. J Clin Microbiol. 2018 Mar 26;56(4):e01507-17. doi: 10.1128/JCM.01507-17. Print 2018 Apr.
About the reviewerView full bio

Dr Toni Hazell, FRCGP
MBBS, BSc, FRCGP, DFSRH, Dip GU med, DRCOG, DCH (London, UK, 2000)
Dr. Toni Hazell qualified from St. Mary’s Hospital Medical School and did her VTS at Northwick Park Hospital.
More in dermatology
- Anogenital warts
- Bullous pemphigoid
- Cellulitis and erysipelas
- Cicatricial pemphigoid
- Discoid lupus erythematosus
- Erythema induratum
- Erythema toxicum neonatorum
- Familial benign pemphigus
- Febrile neutrophilic dermatosis
- Hereditary angio-oedema
- Hyperhidrosis
- Living with skin disease
- Lymphatic filariasis
- Malignant melanoma of skin
- Neurotic excoriation and acne excoriée
- Post-inflammatory hyperpigmentation of skin
- Rubella
- Shingles
- Stevens-Johnson syndrome
- Toxic epidermal necrolysis


